The ubiquitin–proteasome system: A potential target for the MASLD
aInstitute of Pharmacology & Toxicology, Zhejiang Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
bHangzhou Zhongmei Huadong Pharmaceut Co., Ltd., Hangzhou 310011, China
cSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
dCenter for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
eSchool of Medicine, Hangzhou City University, Hangzhou 310015, China
fEngineering Research Center of Innovative Anticancer Drugs, Ministry of Education, Hangzhou 310058, China
gInnovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310058, China
* Corresponding authors.
收起